MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70828

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2026

Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease.

Pei Yiying, Ren Yayun, Tai Dean, Yuan Hai-Yang, Su Ren-Yi, Zulqarnain Muhammad, Puspanathan Pavitratha, Mahadeva Sanjiv, Leow Wei-Qiang, Lim Tony, Tan Chee-Kiat, Chang Pik-Eu Jason, Zheng Ming-Hua, Chan Wah-Kheong, Goh George Boon Bee

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: The predictive ability of histological components in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) has not been well studied. Here, we look at the ability of digital pathology through the components of qFIBs (qfibrosis, qInflammation, qBallooning, qSteatosis) in predicting the risk of Major Adverse Liver Outcomes (MALO).

METHOD: 235 liver biopsy images were retrieved, and the composite end point of MALO, including overall death, hepatic encephalopathy (HE), ascites, variceal haemorrhage and hepatocellular carcinoma (HCC), was studied in parallel with the Non-alcoholic Steatohepatitis Clinical Research Network (NASH-CRN) score and qFIBs.

RESULTS

The predictive power of qFibrosis for MALOs (qF3/4 vs. qF0/1/2, HR 6.64, 95% CI 1.69-26.06, log rank p-value 0.001) was comparable to NASH-CRN (F3/4 vs. F0/1/2, HR 7.02, 95% CI 2.37-20.84, log rank p-value < 0.001). Interestingly, a lower steatosis grade, rather than being a protective factor, correlated with poorer outcomes for both the qFIBs (qS0/1 vs. qS2/3 HR 17.24, 95% CI 3.12-95.32, log rank p value < 0.001) and NASH-CRN (S0/1 vs. S2/3 HR 6.30, 95% CI 2.14-18.61, log rank p value < 0.001). Lower qSteatosis scores of qS1 and below among the cirrhotic group (n = 35) also showed a six-fold higher risk of MALOs (< 1.50 vs. ≥ 1.50, HR 6.40, 95% CI 1.08-37.92, log rank p value < 0.011), likely due to the reduction of steatosis in the cachectic state of a patient with end stage liver disease. Samples with lower percentages of macro-vesicular vacuoles had a fourfold increased risk of MALOs (HR 4.41, 95% CI 1.06-18.43, log rank p value 0.017).

CONCLUSION

Lower steatosis grades in higher fibrosis stages correlate significantly with the occurrence of MALO. Our findings instigate exploration of the process of fat resorption in MASLD and its relation to outcomes.

Для цитирования: Pei Yiying, Ren Yayun, Tai Dean, Yuan Hai-Yang, Su Ren-Yi, Zulqarnain Muhammad, Puspanathan Pavitratha, Mahadeva Sanjiv, Leow Wei-Qiang, Lim Tony, Tan Chee-Kiat, Chang Pik-Eu Jason, Zheng Ming-Hua, Chan Wah-Kheong, Goh George Boon Bee. Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease.. Liver international : official journal of the International Association for the Study of the Liver. 2026. DOI: 10.1111/liv.70828.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.